The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
2022 · Leukemia · 3,654 citations
https://doi.org/10.1038/s41375-022-01613-1
B
Brent L. Wood
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
617
Papers
46.1K
Citations
94
h-index
304
i10-index
Brent L. Wood is an academic researcher from University of Southern California. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Acute Myeloid Leukemia Research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 94, co-authored 525 publications.
ORCID: 0000-0001-7414-3969Papers by this author
worksThe 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
2022 · Leukemia · 3,466 citations
https://doi.org/10.1038/s41375-022-01620-2
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
2018 · Blood · 1,009 citations
https://doi.org/10.1182/blood-2017-09-801498
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
2011 · Cancer Prevention Research · 866 citations
https://doi.org/10.1158/1940-6207.capr-11-0370
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
2021 · Blood · 681 citations
https://doi.org/10.1182/blood.2021013626
Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia
2017 · JAMA Oncology · 529 citations
https://doi.org/10.1001/jamaoncol.2017.0580
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat